You are here

Cost-Effectiveness Analysis of Nasal Continuous Positive Airway Pressure Versus Nasal High Flow Therapy as Primary Support for Infants Born Preterm.

Pubmed ID: 
29550238
Year: 
2018
Month: 
May
Volume: 
196
Citation: 
Huang L, Roberts CT, Manley BJ, Owen LS, Davis PG, Dalziel KM. Cost-Effectiveness Analysis of Nasal Continuous Positive Airway Pressure Versus Nasal High Flow Therapy as Primary Support for Infants Born Preterm. The Journal of pediatrics 196 : 58 - 64.e2(2018) PubMed (Grant IDs: 1079089)